Idogen is a research company. The company's business focus is on developing vaccines for the treatment of diseases that adversely affect the immune system. The vaccines are intended to be used in the cases where autoimmune diseases have occurred and after organ rejection, particularly in the cases where antibodies have been formed against the ingestion of the regular medication of the patient. The company was founded in 2008 and is based in Lund.

Kurser for Idogen AB

Lige nu

+/-
0
%
0,00%
Seneste
0,788
Højeste
0,83
Laveste
0,788
Volumen
220 743
Omsætning (SEK)
176 169
Værdi (MSEK)
38,2

Bestyrelse og direktion

Adm. direktør

  • Anders Karlsson

Bestyrelsesformand

  • Agneta Edberg

Bestyrelse

  • Christina Herder
  • Karin Hoogendoorn
  • Leif G Salford

Film

Kommende rapporter

  • 2020-05-12 Årsstämma 2019

  • 2020-05-12 Delårsrapport 2020-Q1

  • 2020-08-25 Delårsrapport 2020-Q2

  • 2020-10-23 Delårsrapport 2020-Q3

  • 2021-02-09 Bokslutskommuniké 2020